Related Experiment Videos
Cell-type specific processing of neuroendocrine precursor proteins using vaccinia recombinants
G Thomas1, L Thomas, B A Thorne
1Vollum Institute for Advanced Biomedical Research, Oregon Health Sciences University, Portland 97201.
Biochimie
|January 1, 1988
Summary
Human pro-enkephalin processing varies by cell type. While most cells synthesize pro-enkephalin, only AtT-20 cells efficiently cleave it into smaller peptides like Met-enkephalin.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Human pro-enkephalin (hPE) is a precursor to various opioid peptides.
- Understanding cell-type specific processing is crucial for its biological function.
Purpose of the Study:
- To investigate the cell-type specific post-translational modifications and processing of human pro-enkephalin.
- To identify cell lines capable of cleaving hPE into active peptides.
Main Methods:
- Utilized a vaccinia recombinant virus expressing human pro-enkephalin (VV:hPE).
- Infected various cell lines with VV:hPE to analyze protein synthesis and processing.
Main Results:
- All infected cell types synthesized hPE after signal peptide cleavage.
- hPE underwent N-linked glycosylation and other post-translational modifications.
- Only the AtT-20 cell line efficiently processed hPE into smaller peptides, including Met-enkephalin.
Conclusions:
- Cell-type specific differences exist in human pro-enkephalin processing.
- The AtT-20 cell line possesses unique machinery for efficient hPE cleavage and Met-enkephalin production.